An Update on Therapies and Vaccines

In this episode, Goldman Sachs’ Sharmin Mossavar-Rahmani discusses the latest developments on COVID-19 therapies and vaccines with a group of leading experts. This podcast was recorded as a phone call on April 14, 2020.

Participants include:

Dr. Richard Hatchett, CEO of Coalition for Epidemic Preparedness Innovations

Esther Krofah, Executive Director of FasterCures

Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson

Click below to view materials referenced during the podcast:

https://www.goldmansachs.com/insights/talks-at-gs/04-15-2020-an-update-on-covid-19-therapies-and-vaccines-f/presentation.pdf

This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.